CD19 CAR T cell product and disease attributes predict leukemia remission durability

par Finney, Olivia C., Brakke, Hannah, Rawlings-Rhea, Stephanie, Hicks, Roxana, Doolittle, Danielle, Lopez, Marisa, Futrell, Ben, Orentas, Rimas J., Li, Daniel, Gardner, Rebecca, Jensen, Michael C.
Publié dans J Clin Invest (2019)

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy

par Gardner, Rebecca A., Ceppi, Francesco, Rivers, Julie, Annesley, Colleen, Summers, Corinne, Taraseviciute, Agne, Gust, Juliane, Leger, Kasey J., Tarlock, Katherine, Cooper, Todd M., Finney, Olivia C., Brakke, Hannah, Li, Daniel H., Park, Julie R., Jensen, Michael C.
Publié dans Blood (2019)

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

par Gardner, Rebecca A., Finney, Olivia, Annesley, Colleen, Brakke, Hannah, Summers, Corinne, Leger, Kasey, Bleakley, Marie, Brown, Christopher, Mgebroff, Stephanie, Kelly-Spratt, Karen S., Hoglund, Virginia, Lindgren, Catherine, Oron, Assaf P., Li, Daniel, Riddell, Stanley R., Park, Julie R., Jensen, Michael C.
Publié dans Blood (2017)

Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Non-Human Primates

par Taraseviciute, Agne, Tkachev, Victor, Ponce, Rafael, Turtle, Cameron J., Snyder, Jessica M., Liggitt, H. Denny, Myerson, David, Gonzalez-Cuyar, Luis, Baldessari, Audrey, English, Chris, Yu, Alison, Zheng, Hengqi, Furlan, Scott N., Hunt, Daniel J., Hoglund, Virginia, Finney, Olivia, Brakke, Hannah, Blazar, Bruce R., Berger, Carolina, Riddell, Stanley R, Gardner, Rebecca, Kean, Leslie S., Jensen, Michael C.
Publié dans Cancer Discov (2018)